Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Edna Maulana with her PMTCT support group. Photograph by Sydelle Willow Smith
Feature story
Feature story |
20 July 2015
HIV/AIDS

How HIV/TB counsellors save lives: "Thanks to her I’m healthy again"

6 min
35-year old Elena is receiving treatment for XDR-TB in Grozny. She is one of 51 patients MSF is caring for, with a new combination of drugs that have never been used in the country before. Photography by Farida Abdulkadirova
Feature story
Feature story |
13 July 2015
Tuberculosis

Elena: “I’ve been sick for more than 15 years – my goal is to be cured.”

Democratic Republic of Congo, 2015. Bunyakiri vaccination campaign. Photograph by Anna Surinyach
Feature story
Feature story |
26 June 2015
Vaccines
Democratic Republic of the Congo

MSF teams vaccinate 42,000 children against measles in the region of Bunyakiri, DRC

3 min
Hermenegilda. Albazine’s Health Center. Maputo, Mozambique. Photograph by Andre Francois
Feature story
Feature story |
12 June 2015
Research and development

Stockouts in South Africa: Patient testimonies

3 min
Sudanese refugees began streaming across the border into South Sudan in June 2011 when conflict erupted between the Khartoum government and the rebels of the Sudan People’s Liberation Movement-North (SPLM-N) in Sudan’s South Kordofan State. At the height of the crisis in Yida camp last summer, high mortality rates were reported among young children admitted to MSF’s hospital with respiratory tract infections, such as pneumonia, one of the leading causes of death. Photograph by Yann Libessart Photograph by Yann Libessart
Feature story
Feature story |
24 April 2015
Vaccines
EthiopiaSouth Sudan

Pneumonia in Ethiopia: The absurdity of dying of a disease that is preventable

3 min
MSF143351
Feature story
Feature story |
24 March 2015
Tuberculosis
Myanmar

The luxury of MDR-TB treatment in Myanmar: An impossible choice for many

5 min
The waiting area at Kerema General Hospital. MSF has introduced infection control measures to prevent suspected TB patients from infecting other patients. Photograph by Aris Messinis
Feature story
Feature story |
20 March 2015
Tuberculosis

Ready, set, slow down: New and promising DR-TB drugs are grabbing headlines but not reaching patients

4 min
Batangafo IDP camp, Central African Republic. 2015 Photograph by Boris Matous
Feature story
Feature story |
26 February 2015
Central African Republic

Central African Republic: MSF starts a vaccination campaign in the largest displaced persons' camp in the country

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury